ATS Assembly on Pediatrics Advocacy Series Podcast: Policy Related Advocacy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a8/ff/7d/a8ff7dd7-07c0-ff7a-9834-5dadaba0f609/mza_16030161373095204348.jpg/600x600bb.jpg

ATS Assemblies & Sections

American Thoracic Society

13 episodes

22 hours ago

Discussions about pulmonary, critical care, and sleep medicine from our Assemblies & Sections.

All content for ATS Assemblies & Sections is the property of American Thoracic Society and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Discussions about pulmonary, critical care, and sleep medicine from our Assemblies & Sections.

Medicine

Education,

Health & Fitness

ATS Assembly on Pediatrics Advocacy Series Podcast: Policy Related Advocacy

ATS Assemblies & Sections

37 minutes

4 weeks ago

ATS Assembly on Pediatrics Advocacy Series Podcast: Policy Related Advocacy

This is the second episode of our Advocacy Series — a collection of podcasts dedicated to exploring key issues in pediatric pulmonology.

In this episode, Robyn Cohen, MD, MPH, and Will Feldman, MD, DPhil, MPH, share their experiences in policy-related advocacy, focusing on inhaler policy, including topics related to Flovent (Fluticasone). They discuss recent developments, challenges, and barriers in inhaler policy, as well as practical tips and strategies for engaging in policy work.

00:00 – Podcast Opening, Hosts, Topic Setup & Guest Introductions
02:40 – Early Experiences, Origins of Inhaler Advocacy & Media Attention
05:00 – Pediatric vs Adult Perspectives, Policy Challenges & Initial Industry/Regulatory Issues
10:00 – Ongoing Aftermath of Inhaler Discontinuations, Community Impact & System Barriers
15:00 – Market Forces, Dry-Powder Alternatives, Patents & Device Innovation Limitations
19:57 - Patent Protection, New Products, and Market Incentives
22:01 - Environmental Concerns, Formularies, and Clinician Constraints
24:03 - Recommended Resources and Understanding Patents/PBMs
26:09 - Advocacy Challenges, Publishing Op-Eds, and Media Engagement
29:04 - Policy Barriers, Authorized Generics, and Institutional Advocacy Support

Additional Resources:
Dr. Feldman’s Testimony regarding pharmaceutical patents before the Senate Judiciary Committee:
https://www.judiciary.senate.gov/committee-activity/hearings/ensuring-affordable-and-accessible-medications-examining-competition-in-the-prescription-drug-market

A version of Dr. Feldman’s written testimony:
https://pubmed.ncbi.nlm.nih.gov/40197405/

Letter in Peds Pulmonology describing the experience of inhaler advocacy:
https://pubmed.ncbi.nlm.nih.gov/40105398/
Cohen RT, Christy Sadreameli S, Coates AC, Nelson BA, O'Sullivan BP; Members of the Advocacy Subcommittee of the American Thoracic Society Pediatrics Assembly and the New England Pediatric Pulmonary Consortium. Ensuring Inhaler Access for Children: A Case Study in Advocacy by Pediatric Pulmonologists. Pediatr Pulmonol. 2025 Mar;60(3):e71055. doi: 10.1002/ppul.71055. PMID: 40105398.

Op-Ed from Drs. Christy Sadreameli and Dr. Robyn Cohen:
https://www.usnews.com/opinion/articles/2024-04-18/asthma-inhaler-chaos-leaves-us-doctors-and-the-children-we-treat-out-of-breath